BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 2972341)

  • 1. [Immunocytologic study of light cell lines established in vitro from Ewing's sarcoma. Identification of neural markers].
    Lizard-Nacol S; Justrabo E; Mugneret F; Volk C; Turc-Carel C
    C R Seances Soc Biol Fil; 1988; 182(1):118-25. PubMed ID: 2972341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunologic characterization of Ewing's sarcoma using mesenchymal and neural markers.
    Lizard-Nacol S; Lizard G; Justrabo E; Turc-Carel C
    Am J Pathol; 1989 Nov; 135(5):847-55. PubMed ID: 2479272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinicopathological study of Ewing's sarcoma and primitive neuroectodermal tumor].
    Kitagawa Y
    Nihon Seikeigeka Gakkai Zasshi; 1993 Dec; 67(12):1140-50. PubMed ID: 8308411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistological characterization of a Ewing's sarcoma case.
    Lizard-Nacol S; Mugneret F; Turc-Carel C; Justrabo E
    Cancer Detect Prev; 1988; 12(1-6):297-302. PubMed ID: 3180134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immunocytochemical and biochemical studies of an Ewing sarcoma cell line: evidence for neural differentiation in vitro].
    van Valen F; Prior R; Wechsler W; Jürgens H; Schäfer U; Keck E
    Klin Padiatr; 1988; 200(3):267-70. PubMed ID: 2850402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Round cell tumours of bone.
    Roessner A; Jürgens H
    Pathol Res Pract; 1993 Dec; 189(10):111-36. PubMed ID: 8183732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histogenesis of Ewing's sarcoma. An evaluation of intermediate filaments and endothelial cell markers.
    Miettinen M; Lehto VP; Virtanen I
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1982; 41(3):277-84. PubMed ID: 6135272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroectoderm-associated antigens on Ewing's sarcoma cell lines.
    Lipinski M; Braham K; Philip I; Wiels J; Philip T; Goridis C; Lenoir GM; Tursz T
    Cancer Res; 1987 Jan; 47(1):183-7. PubMed ID: 3024814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of cell death by basic fibroblast growth factor in Ewing's sarcoma.
    Sturla LM; Westwood G; Selby PJ; Lewis IJ; Burchill SA
    Cancer Res; 2000 Nov; 60(21):6160-70. PubMed ID: 11085540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Biological markers of diagnostic value in Ewing's sarcoma: the use of antibodies against the antigen p30/32 MIC2, called 013].
    Ladenheim H; García A; Avagnina A; Porta J; Elsner B
    Medicina (B Aires); 1995; 55(2):184-6. PubMed ID: 7565061
    [No Abstract]   [Full Text] [Related]  

  • 11. Sensitivity of Ewing's sarcoma to TRAIL-induced apoptosis.
    Kontny HU; Hämmerle K; Klein R; Shayan P; Mackall CL; Niemeyer CM
    Cell Death Differ; 2001 May; 8(5):506-14. PubMed ID: 11423911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinicopathological study of Ewing's sarcoma/primitive neuroectodermal tumor in oral and maxillofacial region].
    He HW; Liu LK; Li YN; Wang D; He ZX
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2005 Sep; 40(5):379-82. PubMed ID: 16255919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenotypic characterization of Ewing sarcoma cell lines with monoclonal antibodies.
    Lipinski M; Braham K; Philip I; Wiels J; Philip T; Dellagi K; Goridis C; Lenoir GM; Tursz T
    J Cell Biochem; 1986; 31(4):289-96. PubMed ID: 3760036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of Ewing's sarcoma of bone and peripheral neuroepithelioma. An immunocytochemical and ultrastructural analysis of two primitive neuroectodermal neoplasms.
    Navarro S; Cavazzana AO; Llombart-Bosch A; Triche TJ
    Arch Pathol Lab Med; 1994 Jun; 118(6):608-15. PubMed ID: 8204006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Establishment and characterization of a new Ewing's sarcoma cell line from a malignant pleural effusion.
    Schiavo R; Tullio C; La Grotteria M; Andreotti IC; Scarpati B; Romiti L; Bozzi F; Pedrazzoli P; Siena S
    Anticancer Res; 2007; 27(5A):3273-8. PubMed ID: 17970070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nucleophosmin as a candidate prognostic biomarker of Ewing's sarcoma revealed by proteomics.
    Kikuta K; Tochigi N; Shimoda T; Yabe H; Morioka H; Toyama Y; Hosono A; Beppu Y; Kawai A; Hirohashi S; Kondo T
    Clin Cancer Res; 2009 Apr; 15(8):2885-94. PubMed ID: 19351769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is the EWS/FLI-1 fusion transcript specific for Ewing sarcoma and peripheral primitive neuroectodermal tumor? A report of four cases showing this transcript in a wider range of tumor types.
    Thorner P; Squire J; Chilton-MacNeil S; Marrano P; Bayani J; Malkin D; Greenberg M; Lorenzana A; Zielenska M
    Am J Pathol; 1996 Apr; 148(4):1125-38. PubMed ID: 8644855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biphenotypic sarcomas with myogenic and neural differentiation express the Ewing's sarcoma EWS/FLI1 fusion gene.
    Sorensen PH; Shimada H; Liu XF; Lim JF; Thomas G; Triche TJ
    Cancer Res; 1995 Mar; 55(6):1385-92. PubMed ID: 7882340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ewing's sarcoma: transplantation in nude rat.
    Buffe D; Rimbaut C; Mazabraud A; Thiery JP; Zucker JM; Salomon JC; Lascaux V; Rudant C
    Biomed Pharmacother; 1983; 37(5):233-6. PubMed ID: 6661510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of Ewing's sarcoma tumor growth, tumor vessel formation, and vasculogenesis following anti vascular endothelial growth factor receptor-2 therapy.
    Zhou Z; Bolontrade MF; Reddy K; Duan X; Guan H; Yu L; Hicklin DJ; Kleinerman ES
    Clin Cancer Res; 2007 Aug; 13(16):4867-73. PubMed ID: 17699866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.